Opaleye Management Inc. Larimar Therapeutics, Inc. Transaction History

Opaleye Management Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.2 - $13.28 $1.89 Million - $5.96 Million	-449,087 Reduced 72.03%	174,413 $1.32 Million
Q4 2023 Feb 14, 2024	SELL	$2.35 - $4.71 $528,750 - $1.06 Million	-225,000 Reduced 26.52%	623,500 $2.84 Million
Q3 2023 Nov 14, 2023	SELL	$3.08 - $4.49 $1.67 Million - $2.43 Million	-541,500 Reduced 38.96%	848,500 $3.35 Million
Q2 2023 Aug 14, 2023	SELL	$3.13 - $5.27 $34,430 - $57,969	-11,000 Reduced 0.79%	1,390,000 $4.35 Million
Q1 2023 May 12, 2023	SELL	$4.0 - $6.68 $636,000 - $1.06 Million	-159,000 Reduced 10.19%	1,401,000 $6.35 Million
Q4 2022 Feb 10, 2023	SELL	$2.73 - $5.08 $277,870 - $517,062	-101,784 Reduced 6.12%	1,560,000 $6.44 Million
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.64 $1.12 Million - $2.65 Million	728,970 Added 78.15%	1,661,784 $5.32 Million
Q2 2022 Aug 15, 2022	SELL	$1.9 - $3.98 $20,687 - $43,334	-10,888 Reduced 1.15%	932,814 $1.83 Million
Q1 2022 May 16, 2022	BUY	$3.65 - $10.84 $219,365 - $651,484	60,100 Added 6.8%	943,702 $3.82 Million
Q4 2021 Feb 14, 2022	BUY	$8.86 - $13.47 $450,043 - $684,208	50,795 Added 6.1%	883,602 $9.53 Million
Q3 2021 Nov 16, 2021	BUY	$9.61 - $15.11 $1.01 Million - $1.59 Million	105,007 Added 14.43%	832,807 $9.6 Million
Q2 2021 Aug 16, 2021	BUY	$8.0 - $15.2 $5.82 Million - $11.1 Million	727,800 New	727,800 $7.15 Million

128

67.3M

280K

76.3K

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $174M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.